Humulin N (Kwikpen) 100 Unit (Insulin Isophane Human Biosynthetic SUSPENSION) 100 UNIT

HUMULIN N (KWIKPEN) 100 UNIT is a long-acting insulin suspension used for managing blood sugar levels in diabetes. This subcutaneous injection helps regulate glucose and is suitable for daily use.

Strength

100 UNIT

Pack Size

3 ML

Manufacturer / TM Owner

ELI LILLY CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

HUMULIN N (KWIKPEN) 100 UNIT is primarily used for the management of diabetes mellitus. It works by providing a steady release of insulin to help control blood sugar levels throughout the day. This insulin suspension is often prescribed for individuals who require long-acting insulin to maintain stable glucose levels.

Side Effects

Common effects of HUMULIN N (KWIKPEN) 100 UNIT may include localized reactions at the injection site, such as redness or itching. Some users may experience hypoglycemia if the dosage is not properly managed. It is important to monitor blood sugar levels regularly while using this medication.

Precautions & Warnings

HUMULIN N (KWIKPEN) 100 UNIT should be stored properly to maintain its effectiveness. Keep it refrigerated and protect it from light and heat. Always check the expiration date before use. Consult a healthcare provider before starting or adjusting any insulin regimen.

Avoid Interactions

HUMULIN N (KWIKPEN) 100 UNIT may interact with other medications, including oral hypoglycemic agents, beta-blockers, and corticosteroids. Alcohol consumption can also affect blood sugar levels. Always inform your healthcare provider about all medications and supplements you are taking.

Frequently Asked Questions

HUMULIN N (KWIKPEN) 100 UNIT is used for managing blood sugar levels in individuals with diabetes mellitus.

HUMULIN N (KWIKPEN) 100 UNIT is administered subcutaneously, typically once or twice daily as prescribed.

Common side effects may include localized reactions at the injection site and hypoglycemia if not properly managed.

HUMULIN N (KWIKPEN) 100 UNIT may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

HUMULIN N (KWIKPEN) 100 UNIT should be stored in the refrigerator and protected from light and heat.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.